{"organizations": [], "uuid": "273bfa191c53fd1f213503f5b1e57804144e0f72", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-arcturus-and-curevac-enter-into-st/brief-arcturus-and-curevac-enter-into-strategic-collaboration-to-jointly-novel-messenger-rna-therapeutics-idUSFWN1OZ0MI", "country": "US", "domain_rank": 408, "title": "BRIEF-Arcturus and Curevac Enter Into Strategic Collaboration To Jointly Novel Messenger RNA Therapeutics", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-04T14:34:00.000+02:00", "replies_count": 0, "uuid": "273bfa191c53fd1f213503f5b1e57804144e0f72"}, "author": "", "url": "https://www.reuters.com/article/brief-arcturus-and-curevac-enter-into-st/brief-arcturus-and-curevac-enter-into-strategic-collaboration-to-jointly-novel-messenger-rna-therapeutics-idUSFWN1OZ0MI", "ord_in_thread": 0, "title": "BRIEF-Arcturus and Curevac Enter Into Strategic Collaboration To Jointly Novel Messenger RNA Therapeutics", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "curevac ag", "sentiment": "none"}, {"name": "rna therapeutics reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "arcturus therapeutics ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 4, 2018 / 12:34 PM / Updated 9 minutes ago BRIEF-Arcturus and Curevac Enter Into Strategic Collaboration To Jointly Novel Messenger RNA Therapeutics Reuters Staff \nJan 4 (Reuters) - Arcturus Therapeutics Ltd: \n* CO, CUREVAC AG ENTER INTO STRATEGIC COLLABORATION TO JOINTLY DISCOVER, DEVELOP,COMMERCIALIZE NOVEL MESSENGER RNA THERAPEUTICS \n* DEVELOPMENT COSTS WILL BE SHARED BETWEEN COS,WITH PLANS TO CO-COMMERCIALIZE PRODUCTS IN FUTURE UNDER PROFIT SHARING ARRANGEMENT Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-04T14:34:00.000+02:00", "crawled": "2018-01-04T14:47:03.094+02:00", "highlightTitle": ""}